Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mblox was a global leader in application-to-person (A2P) mobile messaging, providing critical communication infrastructure for various industries, including healthcare. In the life sciences and healthcare sectors, the company's platform was extensively used for mHealth initiatives, such as patient appointment reminders, clinical trial recruitment, and medication adherence alerts. By enabling secure and reliable SMS-based communication, Mblox helped healthcare providers and pharmaceutical companies improve patient engagement and operational efficiency. The company was acquired by CLX Communications (now Sinch) in 2016, integrating its messaging capabilities into a broader cloud communications portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mblox.